Silicon Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 117.10 Cr
- Paid Up Capital ₹ 109.97 Cr
- Company Age 17 Year, 5 Days
- Last Filing with ROC 31 Mar 2020
- Satisfied Charges ₹ 45.00 Cr
- Revenue Growth 30.61%
- Profit Growth -21.54%
- Ebitda 12.02%
- Net Worth 34.12%
- Total Assets -15.12%
About Silicon Life Sciences
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100TG2008PTC057669
- Company No.
057669
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Feb 2008
- Date of AGM
24 Aug 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Silicon Life Sciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suryanarayana Mula  | CFO | 23-May-2019 | Current |
| Venkata Racharla | Company Secretary | 15-Apr-2019 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nityananda Kambam | Director | 30-Aug-2013 | Current |
| Venkateswararao Kondreddy | Director | 28-Feb-2018 | Current |
| Jacob Joseph | Whole-Time Director | 23-May-2019 | Current |
| Sapna | Director | 23-May-2019 | Current |
Financial Performance of Silicon Life Sciences.
Silicon Life Sciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 30.61% increase. The company also saw a substantial fall in profitability, with a 21.54% decrease in profit. The company's net worth Soared by an impressive increase of 34.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Silicon Life Sciences?
In 2020, Silicon Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aurobindo Pharma LtdNityananda Kambam is a mutual person
- Aurobindo Antibiotics Private Limited
Nityananda Kambam is a mutual person
- Apl Healthcare Limited
Nityananda Kambam and Suryanarayana Mula are mutual person
- Apitoria Pharma Private Limited
Nityananda Kambam is a mutual person
- Raidurgam Developers Limited
Nityananda Kambam and Venkateswararao Kondreddy are mutual person
- Aurobindo Pharma Foundation
Nityananda Kambam is a mutual person
Charges (Loans)
₹0
₹45.00 Cr
Charges Breakdown by Lending Institutions
- State Bank Of Hyderabad : 30.00 Cr
- Yes Bank Limited : 15.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Feb 2016 | Yes Bank Limited | ₹15.00 Cr | Satisfied |
| 02 Jul 2011 | State Bank Of Hyderabad | ₹30.00 Cr | Satisfied |
How Many Employees Work at Silicon Life Sciences?
Unlock and access historical data on people associated with Silicon Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Silicon Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Silicon Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
